humans |
152 |
male |
114 |
adolescent |
108 |
female |
105 |
child |
104 |
covid-19 |
99 |
children |
97 |
chinese |
93 |
child, preschool |
86 |
adult |
85 |
hong kong |
84 |
infant |
71 |
animals |
63 |
middle aged |
60 |
epidemiology |
57 |
hong kong - epidemiology |
56 |
sars-cov-2 |
45 |
interprofessional education |
44 |
pediatrics |
43 |
cells, cultured |
39 |
mice |
39 |
genetic predisposition to disease |
38 |
infant, newborn |
36 |
risk factors |
34 |
vaccine |
34 |
pediatric |
32 |
medical sciences |
31 |
prevalence |
31 |
health-related quality of life |
30 |
adolescents |
29 |
aged |
29 |
phenotype |
29 |
partnership model |
28 |
social interaction anxiety |
28 |
mental health |
27 |
cardiomyocytes |
26 |
chemicals and cas registry numbers |
26 |
cohort studies |
26 |
cross-sectional studies |
26 |
pregnancy |
26 |
treatment outcome |
26 |
case-control studies |
25 |
incidence |
25 |
magnetic resonance imaging |
25 |
apoptosis |
24 |
genotype |
24 |
nasopharyngeal carcinoma |
24 |
asian continental ancestry group - genetics |
23 |
china |
23 |
coronavirus |
23 |
mutation |
23 |
prognosis |
23 |
prospective studies |
23 |
retrospective studies |
23 |
reverse transcriptase polymerase chain reaction |
23 |
sars |
23 |
signal transduction |
23 |
cytokines |
22 |
public health |
22 |
cell line |
21 |
embryonic stem cells |
21 |
infants |
21 |
polymorphism, single nucleotide - genetics |
21 |
rats |
21 |
safety |
21 |
school closure |
21 |
screen time |
21 |
base sequence |
20 |
bone marrow transplantation |
20 |
complications |
20 |
influenza |
20 |
reference values |
20 |
up-regulation |
20 |
amino acid sequence |
19 |
child development |
19 |
hospitalization |
19 |
immunotherapy |
19 |
physical activity |
19 |
polymorphism, genetic |
19 |
disease outbreaks - statistics & numerical data |
18 |
genome-wide association study |
18 |
hepatocellular carcinoma |
18 |
influenza a virus, h1n1 subtype - immunology |
18 |
molecular sequence data |
18 |
paediatrics |
18 |
sle |
18 |
systemic lupus erythematosus |
18 |
time factors |
18 |
vaccination |
18 |
young adult |
18 |
animal tissue |
17 |
inflammation |
17 |
magnetic resonance imaging - methods |
17 |
perceived stress |
17 |
whole-exome sequencing |
17 |
adult learning principles |
16 |
alleles |
16 |
biology |
16 |
child psychosocial problems |
16 |
chinese children |
16 |
chromosome aberration |
16 |
collaborative practice |
16 |
cytokine |
16 |
disease models, animal |
16 |
evaluation |
16 |
healthcare workers |
16 |
heterozygote |
16 |
home confinement |
16 |
hospital policies |
16 |
immunoglobulin |
16 |
influenza, human - epidemiology - immunology - virology |
16 |
low-income families |
16 |
psychological wellbeing |
16 |
adolescence |
15 |
association |
15 |
autoimmunity |
15 |
child health |
15 |
child maltreatment |
15 |
congenital heart disease |
15 |
cord blood |
15 |
coronavac |
15 |
coronavirus disease 2019 |
15 |
fatal outcome |
15 |
latent class analysis |
15 |
mediation |
15 |
omicron |
15 |
osteoporosis |
15 |
pandemic |
15 |
pandemics |
15 |
polymerase chain reaction |
15 |
population surveillance |
15 |
risk assessment |
15 |
seroepidemiologic studies |
15 |
single nucleotide polymorphism |
15 |
stool |
15 |
vitamin d |
15 |
acute disease |
14 |
age factors |
14 |
antibodies, viral - blood |
14 |
asia |
14 |
asian |
14 |
asian continental ancestry group |
14 |
autophagy |
14 |
cluster analysis |
14 |
coronavirus infection |
14 |
depression |
14 |
epilepsy |
14 |
epstein-barr virus |
14 |
gene expression |
14 |
health outcomes |
14 |
immunity |
14 |
immunity, innate |
14 |
innate immunity |
14 |
kawasaki disease |
14 |
obesity |
14 |
phylogeny |
14 |
sensitivity and specificity |
14 |
vaccine effectiveness |
14 |
antigens, cd - genetics |
13 |
cancer susceptibility genes |
13 |
cell adhesion molecules - genetics |
13 |
cell differentiation |
13 |
china - epidemiology |
13 |
cross protection |
13 |
developmental delay |
13 |
disease progression |
13 |
down syndrome |
13 |
early-age onset |
13 |
gene frequency |
13 |
hematopoietic stem cell transplantation |
13 |
hypoxia |
13 |
immunohistochemistry |
13 |
immunology |
13 |
immunophenotyping |
13 |
l-lactate dehydrogenase - blood |
13 |
leukemia |
13 |
lupus erythematosus, systemic - genetics |
13 |
lymphocyte subsets |
13 |
models, biological |
13 |
mortality |
13 |
mst1r |
13 |
myocardial infarction |
13 |
neonates |
13 |
rats, sprague-dawley |
13 |
severity of illness index |
13 |
viral load |
13 |
whole exome sequencing |
13 |
allergy |
12 |
anorectal malformation |
12 |
asparaginase |
12 |
asthma |
12 |
bmi |
12 |
breastfeeding |
12 |
cardiac differentiation |
12 |
cognition |
12 |
convalescence |
12 |
cytokines - biosynthesis |
12 |
dendritic cells |
12 |
diagnosis |
12 |
dna methylation |
12 |
efficacy |
12 |
electrophysiology |
12 |
ephrin-a2 - genetics |
12 |
false positive |
12 |
gene expression regulation |
12 |
hospitalization - statistics & numerical data |
12 |
human |
12 |
infection |
12 |
influenza, human - immunology - virology |
12 |
interferon |
12 |
lupus |
12 |
meta-analysis |
12 |
neutralization tests |
12 |
nk cells |
12 |
physical fitness |
12 |
rna, messenger - metabolism |
12 |
sars-cov-2 rbd igg |
12 |
serology |
12 |
t cell response |
12 |
uhrf1bp1 |
12 |
wnt signaling pathway |
12 |
algorithms |
11 |
analysis of variance |
11 |
antigens, cd3 - genetics |
11 |
antimicrobial resistance |
11 |
autoantibodies - blood |
11 |
cd247 |
11 |
childhood |
11 |
collagen |
11 |
cytotoxicity |
11 |
diffusion |
11 |
dna mutational analysis |
11 |
feces - virology |
11 |
gwas |
11 |
human embryonic stem cells |
11 |
hypersensitivity |
11 |
intellectual disability |
11 |
lupus erythematosus, systemic - enzymology - genetics |
11 |
lupus erythematosus, systemic - genetics - immunology |
11 |
mice, inbred c57bl |
11 |
mutation - genetics |
11 |
next-generation sequencing |
11 |
oxidative stress |
11 |
pilot projects |
11 |
proarrhythmias |
11 |
reproducibility of results |
11 |
seasons |
11 |
severe acute respiratory syndrome |
11 |
statistics & research methods |
11 |
stem cell |
11 |
t-lymphocytes, cytotoxic - immunology |
11 |
treatment |
11 |
γδ-t cells |
11 |
adaptor proteins, signal transducing - genetics - immunology - metabolism |
10 |
adenovirus |
10 |
age of onset |
10 |
all-cause pneumonia |
10 |
antibodies, antinuclear - blood |
10 |
antineoplastic combined chemotherapy protocols - therapeutic use |
10 |
anxiety |
10 |
attention-deficit/hyperactivity disorder |
10 |
autism spectrum disorder |
10 |
bidirectional relationship |
10 |
birds |
10 |
brain microstructure |
10 |
child day care centers |
10 |
cyclooxygenase 2 - biosynthesis - genetics |
10 |
cyclooxygenase 2 inhibitors |
10 |
cytokines - metabolism |
10 |
dead-box rna helicases - genetics - immunology - metabolism |
10 |
dendritic cells - immunology |
10 |
diagnosis, differential |
10 |
diffusion kurtosis imaging |
10 |
disease burden |
10 |
dose-response relationship, drug |
10 |
drug resistance |
10 |
embryonic stem cells - cytology |
10 |
epithelial cells - immunology - metabolism |
10 |
exome sequencing |
10 |
follow-up studies |
10 |
functional outcome |
10 |
genetic testing |
10 |
genetics |
10 |
haplotypes |
10 |
heart |
10 |
hepatoblastoma |
10 |
herd immunity |
10 |
human leukocyte antigens |
10 |
immunodeficiency |
10 |
induced pluripotent stem cells |
10 |
influenza a virus, h1n1 subtype - genetics - immunology |
10 |
influenza a virus, h1n1 subtype - immunology - isolation and purification - pathogenicity |
10 |
influenza a virus, h5n1 subtype - genetics - immunology |
10 |
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity |
10 |
influenza in birds - enzymology - immunology - virology |
10 |
influenza virus |
10 |
influenza, human - enzymology - virology |
10 |
influenza, human - epidemiology - virology |
10 |
influenza, human - immunology - metabolism - virology |
10 |
influenza, human - mortality |
10 |
interferon regulatory factor-3 - metabolism |
10 |
interferon-gamma - metabolism |
10 |
interrupted time series analysis |
10 |
intracellular signaling peptides and proteins - genetics |
10 |
intracranial germ cell tumor |
10 |
janus kinases - immunology |
10 |
linkage disequilibrium |
10 |
macrophages - immunology |
10 |
macrophages - immunology - metabolism |
10 |
meningitis |
10 |
molecular tumour board |
10 |
mri |
10 |
multivariate analysis |
10 |
nerve tissue proteins - genetics |
10 |
neuroblastoma |
10 |
neurotoxicity |
10 |
nf-kappa b - metabolism |
10 |
p38 mitogen-activated protein kinases - metabolism |
10 |
paracrine communication - immunology |
10 |
parental stress |
10 |
patient admission - statistics and numerical data |
10 |
pneumococcal conjugate vaccines |
10 |
polymorphism, single nucleotide |
10 |
population-based electronic health records |
10 |
population-based study |
10 |
precision oncology |
10 |
prediction |
10 |
pulmonary alveoli - immunology - metabolism |
10 |
quality control |
10 |
questionnaires |
10 |
radiation therapy |
10 |
receptor, interferon alpha-beta - immunology |
10 |
recurrence |
10 |
respiratory tract infections - virology |
10 |
rna, small interfering - genetics |
10 |
rna, viral - metabolism |
10 |
sequence-directed therapy |
10 |
syndrome |
10 |
t-lymphocytes |
10 |
telomere |
10 |
toll-like receptor 3 - metabolism |
10 |
transplantation |
10 |
validation |
10 |
age-stratified |
9 |
animals, newborn |
9 |
anisotropy |
9 |
anti-bacterial agents - pharmacology |
9 |
behavior change |
9 |
body height |
9 |
carrier proteins - genetics |
9 |
cell differentiation - drug effects |
9 |
clustering |
9 |
cross reactions |
9 |
diarrhoea |
9 |
disease surveillance |
9 |
dna-binding proteins - genetics |
9 |
drug |
9 |
european continental ancestry group |
9 |
exercise |
9 |
gene deletion |
9 |
germ cells |
9 |
haplotype |
9 |
heart - physiology |
9 |
il-10 |
9 |
immunoglobulin g - blood |
9 |
injury |
9 |
intradermal |
9 |
isolation |
9 |
longitudinal studies |
9 |
markov chains |
9 |
maternal |
9 |
mobile game |
9 |
molecular epidemiology |
9 |
monte carlo method |
9 |
nasopharynx - virology |
9 |
neurotoxicity syndromes |
9 |
pedigree |
9 |
pharmacovigilance |
9 |
preschooler |
9 |
radiotherapy |
9 |
rare diseases |
9 |
relapse |
9 |
serum 25-hydroxyvitamin d |
9 |
severe acute respiratory syndrome - blood - epidemiology |
9 |
sex factors |
9 |
surveillance |
9 |
survival rate |
9 |
travel history |
9 |
urine - virology |
9 |
vaccine safety |
9 |
wiskott-aldrich syndrome |
9 |
abdominal pain |
8 |
age distribution |
8 |
aged, 80 and over |
8 |
allergology and immunology |
8 |
anaphylaxis |
8 |
antiviral agents - therapeutic use |
8 |
bacteria |
8 |
bintrafusp alfa |
8 |
biological markers |
8 |
bnt162b2 mrna covid-19 vaccines |
8 |
cell movement - drug effects |
8 |
child abuse |
8 |
child abuse and neglect |
8 |
chromatography, high pressure liquid |
8 |
coronavirus - classification - genetics - isolation & purification |
8 |
coronavirus infections - epidemiology - physiopathology - virology |
8 |
correlative biomarkers |
8 |
coughing |
8 |
covid‐19 |
8 |
cyclin a2 |
8 |
diarrhea |
8 |
disease predisposition |
8 |
dna - genetics |
8 |
drug regulatory |
8 |
dysmorphism |
8 |
embryonic stem cell |
8 |
embryonic stem cells - cytology - drug effects - transplantation |
8 |
embryonic stem cells - cytology - metabolism |
8 |
evolution, molecular |
8 |
exons - genetics |
8 |
family hardship |
8 |
family health |
8 |
ferric compounds - adverse effects |
8 |
founder mutation |
8 |
gastroenteritis |
8 |
gene transfer |
8 |
green fluorescent proteins - analysis - biosynthesis |
8 |
hbv integration |
8 |
health disparity |
8 |
health equity |
8 |
hypercytokinemia |
8 |
hyperinsulinism |
8 |
in situ hybridization, fluorescence |
8 |
inactivated vaccine |
8 |
infection control |
8 |
influenza a virus, h1n1 subtype - genetics - isolation & purification - physiology |
8 |
influenza vaccine |
8 |
injury prevention |
8 |
kir genetics |
8 |
lupus nephritis |
8 |
lymphocyte activation |
8 |
lytic cycle |
8 |
mice, knockout |
8 |
mobile phone |
8 |
model |
8 |
mrna vaccine |
8 |
myocytes, cardiac - cytology - drug effects |
8 |
nanoparticles - adverse effects |
8 |
nanopore sequencing |
8 |
nasopharynx - microbiology |
8 |
nose - virology |
8 |
nsp1 |
8 |
offspring |
8 |
oncology medical sciences |
8 |
orphan drug policy |
8 |
paediatric gastroenterology |
8 |
parents |
8 |
pediatric population |
8 |
phenotyping |
8 |
polymerase chain reaction - methods |
8 |
predictive value of tests |
8 |
prenatal diagnosis |
8 |
prenatal exome |
8 |
probability |
8 |
protection |
8 |
qualitative |
8 |
recombination, genetic |
8 |
recurrent or metastatic nasopharyngeal cancer |
8 |
respiratory system - virology |
8 |
respiratory tract infections |
8 |
respiratory tract infections - epidemiology - physiopathology - virology |
8 |
rhinitis |
8 |
risk stratification |
8 |
rt‐pcr |
8 |
sars‐cov‐2 |
8 |
seizures, febrile - epidemiology |
8 |
sequence analysis, dna |
8 |
serial |
8 |
sex knowledge |
8 |
sexual risk behaviors |
8 |
sexually transmitted infections |
8 |
sleep duration |
8 |
splicing |
8 |
staining and labeling - methods |
8 |
streptococcus pneumoniae |
8 |
structural equation modeling |
8 |
superparamagnetic iron oxide |
8 |
thalassemia |
8 |
tissue engineering |
8 |
transcription, genetic |
8 |
translation to patients |
8 |
treatment access |
8 |
tspyl2 |
8 |
urine |
8 |
vaccine-related myocarditis |
8 |
variants of unknown clinical significance |
8 |
ventricular remodeling |
8 |
viral load - physiology |
8 |
virus cultivation |
8 |
virus shedding |
8 |
young adults |
8 |
youth sexuality |
8 |
2009 h1n1 influenza |
7 |
action potential |
7 |
animal cell |
7 |
anoxia - metabolism |
7 |
antibody titer |
7 |
antigen presentation |
7 |
antigens, cd11b - genetics |
7 |
antigens, differentiation - biosynthesis |
7 |
antimutagenic agents - pharmacology |
7 |
antiviral agents - administration and dosage - therapeutic use |
7 |
arrhythmias, cardiac - etiology |
7 |
asian continental ancestry group - ethnology - genetics |
7 |
autoantibodies |
7 |
b-lymphocytes - immunology |
7 |
baby-friendly hospital initiative |
7 |
baby-friendly initiative |
7 |
behavior |
7 |
biomarkers |
7 |
bnt162b2 vaccine |
7 |
bocavirus - classification - genetics - isolation & purification |
7 |
body mass index |
7 |
bone marrow transplantation - adverse effects |
7 |
calcium - metabolism |
7 |
cancer |
7 |
cardiac |
7 |
cardiac infection |
7 |
carrier state - microbiology |
7 |
case report |
7 |
cell proliferation |
7 |
cervical screening |
7 |
chemotherapy |
7 |
child behaviour |
7 |
cobalt - pharmacology |
7 |
codon, nonsense |
7 |
cohort study |
7 |
comm child health |
7 |
common cold - virology |
7 |
community |
7 |
comorbidity |
7 |
cord blood transplantation |
7 |
coronavirus - immunology |
7 |
coronavirus infections - virology |
7 |
coronavirus oc43, human - classification - genetics - isolation and purification |
7 |
covid-19 pandemic |
7 |
cytokines - biosynthesis - genetics |
7 |
development |
7 |
disease susceptibility |
7 |
dna fingerprinting |
7 |
dna, complementary - genetics |
7 |
drug resistance, bacterial |
7 |
duchenne muscular dystrophy |
7 |
early childhood exposure |
7 |
early-life activities |
7 |
ebv |
7 |
echocardiography |
7 |
elder abuse |
7 |
embryonic stem cells - transplantation |
7 |
enzyme-linked immunosorbent assay |
7 |
epidemiology, molecular |
7 |
epistasis |
7 |
epstein–barr virus |
7 |
ets1 |
7 |
exome |
7 |
family financial pressure |
7 |
family functioning |
7 |
fetal blood |
7 |
fish |
7 |
gastroenteritis - epidemiology - physiopathology - virology |
7 |
genome sequencing |
7 |
genome, viral |
7 |
glycosylation |
7 |
graft survival |
7 |
graft-versus-host disease |
7 |
health disparities |
7 |
healthy eating |
7 |
histocompatibility testing |
7 |
homeostasis - drug effects |
7 |
hpv vaccination |
7 |
human leukocyte antigen |
7 |
hypertension |
7 |
hypoxia inducible factor-1α |
7 |
hypoxia-inducible factor 1, alpha subunit - biosynthesis |
7 |
il-17 |
7 |
immune thrombocytopenia |
7 |
immunological profiles |
7 |
inborn errors of immunity |
7 |
influenza a virus - immunology |
7 |
influenza a virus - isolation & purification |
7 |
influenza a virus, h1n1 subtype - genetics |
7 |
influenza vaccines - administration & dosage - immunology |
7 |
influenza, human - drug therapy - epidemiology - virology |
7 |
intimate partner abuse |
7 |
intimate partner violence |
7 |
leukocytes, mononuclear - virology |
7 |
lupus erythematosus |
7 |
lupus erythematosus, systemic - ethnology - genetics |
7 |
lupus erythematosus, systemic - ethnology - immunology |
7 |
macrophages |
7 |
management |
7 |
mice, transgenic |
7 |
microencapsulation |
7 |
microrna |
7 |
microspheres |
7 |
multigene family |
7 |
myelosuppression |
7 |
myocardium - cytology - metabolism |
7 |
myocardium - metabolism |
7 |
myocytes, cardiac - cytology - metabolism |
7 |
myocytes, cardiac - transplantation |
7 |
nephritis - ethnology - genetics |
7 |
organ specificity - drug effects |
7 |
oseltamivir - administration and dosage - therapeutic use |
7 |
parvoviridae infections - epidemiology - physiopathology - virology |
7 |
placebos - administration & dosage |
7 |
pluripotent stem cells |
7 |
prematurity |
7 |
prevention |
7 |
protein-serine-threonine kinases - genetics |
7 |
psychosocial development |
7 |
quality of life |
7 |
registries |
7 |
respiratory syncytial viruses - isolation & purification |
7 |
respiratory tract infections - epidemiology - virology |
7 |
reverse transcriptase polymerase chain reaction - methods |
7 |
rhinovirus - classification - genetics |
7 |
rna, messenger - analysis |
7 |
rna, messenger - biosynthesis |
7 |
rna, messenger - genetics - metabolism |
7 |
saliva |
7 |
sarcoplasmic reticulum function |
7 |
sars-coronavirus seroprevalence |
7 |
school closures |
7 |
school-aged children |
7 |
sequence deletion |
7 |
sex distribution |
7 |
sexual behaviour |
7 |
sleep |
7 |
snoring |
7 |
social support |
7 |
sodium channel |
7 |
stakeholders |
7 |
statistics as topic |
7 |
stem cell transplantation - adverse effects |
7 |
survival analysis |
7 |
systematic review |
7 |
systemic |
7 |
telomere length |
7 |
transplantation, homologous |
7 |
troponin t - biosynthesis |
7 |
vaccination - methods |
7 |
vascular endothelial growth factor a - metabolism |
7 |
ventricular function |
7 |
β-thalassemia major |
7 |
22q11.2 deletion |
6 |
22q11.2 deletion syndrome (22q11.2ds) |
6 |
25(oh)d |
6 |
acyclovir - therapeutic use |
6 |
adaptive immunity |
6 |
adolescent development |
6 |
agammaglobulinemia |
6 |
animal experiment |
6 |
animal model |
6 |
antibiotic prophylaxis |
6 |
antibodies |
6 |
antibodies, neutralizing - blood |
6 |
apoptosis - immunology |
6 |
apoptotic cells |
6 |
array comparative genomic hybridization |
6 |
autism spectrum disorder (asd) |
6 |
autoimmune diseases |
6 |
bayes theorem |
6 |
benzofurans - pharmacology |
6 |
biopsy |
6 |
blood |
6 |
blood pressure monitoring, ambulatory |
6 |
bnt162b2 |
6 |
bone loss |
6 |
bone marrow aspiration |
6 |
bone mineral testing |
6 |
cardiovascular health |
6 |
carrier proteins - blood - genetics |
6 |
carrier state |
6 |
caveolins |
6 |
cell composition |
6 |
cell division |
6 |
cell line, tumor |
6 |
cell lineage-specific |
6 |
cfu-f |
6 |
challenge |
6 |
child behavior |
6 |
child welfare |
6 |
china - ethnology |
6 |
chinese medicine |
6 |
chromosomes, human, pair 1 - genetics |
6 |
clinical phenotype |
6 |
coculture techniques |
6 |
combined modality therapy |
6 |
confidence intervals |
6 |
conotruncal anomaly |
6 |
conservation |
6 |
contrast media |
6 |
cost-benefit analysis |
6 |
cox regression |
6 |
cross-cultural comparison |
6 |
cytogenetics |
6 |
cytoprotection |
6 |
cytotoxicity, immunologic |
6 |
dendritic cell |
6 |
diarrhea - microbiology |
6 |
diffusion magnetic resonance imaging |
6 |
disease transmission, infectious - statistics & numerical data |
6 |
down-regulation |
6 |
dysglycaemia |
6 |
early child development |
6 |
endemic diseases - statistics & numerical data |
6 |
enzyme inhibitors - pharmacology |
6 |
epicardial patch |
6 |
extracellular matrix |
6 |
extracellular vesicle |
6 |
extracellular vesicles |
6 |
family breakfast |
6 |
family dinner |
6 |
family meal |
6 |
family satisfaction |
6 |
fasting glucose |
6 |
fatty acids |
6 |
fecal |
6 |
fever - diagnosis |
6 |
gastroenteritis - epidemiology - virology |
6 |
gastrointestinal diseases - microbiology |
6 |
gc gene |
6 |
gene expression regulation - drug effects |
6 |
genetic risk predisposition |
6 |
genetic variation |
6 |
gpx3 |
6 |
gram-positive bacteria - isolation & purification |
6 |
gram-positive bacterial infections - microbiology |
6 |
h7n9 |
6 |
haploidentical |
6 |
hcc |
6 |
head and neck neoplasms |
6 |
health empowerment |
6 |
hemagglutination inhibition tests |
6 |
hemagglutinins, viral - immunology |
6 |
heptavalent pneumococcal conjugate vaccine |
6 |
hipsc-mscs |
6 |
histocompatibility antigens class i - analysis |
6 |
hiv-1 - pathogenicity |
6 |
hong kong chinese |
6 |
hong kong/epidemiology |
6 |
human induced pluripotent stem cells |
6 |
human rhinovirus c |
6 |
hypoglycaemia |
6 |
il-2 |
6 |
image processing, computer-assisted |
6 |
immune dysregulation |
6 |
immune reconstitution |
6 |
immunocompromised host |
6 |
influenza a virus, h1n1 subtype - immunology - pathogenicity |
6 |
influenza a virus, h1n1 subtype - isolation and purification |
6 |
influenza a virus, h1n1 subtype - physiology |
6 |
influenza a virus, h5n1 subtype |
6 |
influenza a virus, h5n1 subtype - physiology |
6 |
influenza a virus, h9n2 subtype - physiology |
6 |
influenza b |
6 |
influenza, human - complications - diagnosis - epidemiology |
6 |
influenza, human - epidemiology - prevention & control - virology |
6 |
influenzavirus a - genetics - immunology - pathogenicity |
6 |
insulin-like growth factor i - pharmacology |
6 |
interleukin 10 |
6 |
internal capsule - pathology |
6 |
introns - genetics |
6 |
intussusception |
6 |
karyotype |
6 |
karyotyping |
6 |
killer cells, natural - immunology |
6 |
killer cells, natural - immunology - virology |
6 |
killer cells, natural - virology |
6 |
kinetics |
6 |
lateral ventricles |
6 |
leukoencephalopathy |
6 |
locomotion |
6 |
low income |
6 |
mass vaccination |
6 |
mesenchymal stromal cell |
6 |
metapneumovirus - isolation & purification |
6 |
methylationepic |
6 |
microbial sensitivity tests |
6 |
microbiota |
6 |
molecular genetics |
6 |
mutation, missense |
6 |
myocardial infarction - pathology - physiopathology - surgery |
6 |
myocarditis |
6 |
natural killer (nk) cell |
6 |
necrosis |
6 |
neonatal rat |
6 |
neurodegeneration |
6 |
neurodevelopment |
6 |
neurofibromatosis |
6 |
nitric oxide |
6 |
novel mutation |
6 |
oncology |
6 |
oral glucose tolerance test |
6 |
orthomyxoviridae - immunology - pathogenicity |
6 |
orthomyxoviridae - isolation & purification |
6 |
outcome |
6 |
paediatric |
6 |
paediatric-onset |
6 |
paramyxoviridae infections - diagnosis - epidemiology - virology |
6 |
parkinson's disease |
6 |
pediatric cardiology |
6 |
peer support |
6 |
pericardium - pathology - physiopathology |
6 |
pharynx - virology |
6 |
picornaviridae infections - epidemiology - virology |
6 |
pik3ca |
6 |
pneumococcal infections - microbiology |
6 |
pneumococcal vaccines |
6 |
polycystic ovary syndrome |
6 |
polymorphism |
6 |
prepulse inhibition |
6 |
promoter regions, genetic |
6 |
prosthesis implantation - methods |
6 |
randomized controlled trial |
6 |
receptors, antigen, t-cell, gamma-delta - immunology |
6 |
regulation |
6 |
regulatory t cell |
6 |
repressor proteins |
6 |
respiratory syncytial virus infections - diagnosis - epidemiology - virology |
6 |
respiratory tract infections - diagnosis - epidemiology - virology |
6 |
retrospective cohort |
6 |
rhinovirus - classification - genetics - isolation and purification |
6 |
rickets |
6 |
rna, viral - genetics |
6 |
rna, viral - genetics - isolation & purification |
6 |
ryanodine receptor |
6 |
sars virus - immunology - isolation & purification |
6 |
sequence alignment |
6 |
serotyping |
6 |
severe combined immunodeficiency |
6 |
sex characteristics |
6 |
short stature |
6 |
small for gestational age |
6 |
social movement |
6 |
spinal muscular atrophy |
6 |
stat4 transcription factor - genetics |
6 |
streptococcus pneumoniae - drug effects - immunology |
6 |
streptococcus pneumoniae - immunology |
6 |
susceptibility |
6 |
t cell epitope |
6 |
t-lymphocyte subsets - immunology |
6 |
t-lymphocytes - immunology - metabolism |
6 |
th1 cells - immunology |
6 |
thalassaemia |
6 |
tissue donors |
6 |
traditional chinese medicine |
6 |
transcription factor |
6 |
translocation, genetic |
6 |
tumor |
6 |
tumor microenvironment |
6 |
tumor necrosis factor-alpha - biosynthesis |
6 |
tumor necrosis factor-alpha - biosynthesis - genetics |
6 |
tumor suppressor gene |
6 |
vaccine side effect |
6 |
vaccine-induced myocarditis |
6 |
vaccines, conjugate |
6 |
vaccines, inactivated - administration & dosage - immunology |
6 |
vdr gene |
6 |
ventricular dysfunction, left - physiopathology - surgery |
6 |
ventricular remodeling - physiology |
6 |
virion - immunology |
6 |
virus internalization |
6 |
vitamin d-binding protein |
6 |
γδ t cells |
6 |
acute graft-versus-host disease |
5 |
acute lymphoblastic leukaemia |
5 |
adhd |
5 |
adrenergic effects |
5 |
adulthood |
5 |
adverse events |
5 |
aim2 |
5 |
aldosterone synthase deficiency |
5 |
alport's syndrome |
5 |
alps-like disease |
5 |
ampk |
5 |
antigens, cd40 - immunology |
5 |
antigens, cd56 - metabolism |
5 |
antioxidation |
5 |
antiviral |
5 |
antiviral agents - pharmacology |
5 |
arthritis, experimental - etiology - genetics - immunology - pathology |
5 |
asia pacific |
5 |
astrocytes - metabolism |
5 |
autism |
5 |
autoimmune diseases - etiology - genetics - immunology |
5 |
avian influenza virus (aiv) |
5 |
b cells |
5 |
b lymphocytes |
5 |
b-cell activating factor |
5 |
b-cell activation factor receptor |
5 |
b-lymphocytes - cytology - immunology |
5 |
b-lymphocytes - immunology - metabolism |
5 |
b-lymphocytes - immunology - pathology |
5 |
bacteremia - complications - epidemiology - etiology |
5 |
bacteria - isolation & purification |
5 |
beta-thalassemia - blood - immunology - therapy |
5 |
bioactivity-guided fractionation |
5 |
bioartificial pacemaker |
5 |
blood platelets - microbiology |
5 |
bone marrow transplant |
5 |
brain - pathology |
5 |
bronchiectasis |
5 |
c-type lectins |
5 |
calcium signaling |
5 |
cancer chemotherapy |
5 |
cancer survivors |
5 |
cancer treatment |
5 |
candida |
5 |
cardiac pacing, artificial |
5 |
cardiotoxicity |
5 |
cd55 |
5 |
cd8-positive t-lymphocytes - cytology - immunology |
5 |
cell culture techniques - methods |
5 |
cell fusion |
5 |
cell lineage - immunology |
5 |
cell migration |
5 |
cell proliferation - drug effects |
5 |
cell-free dna |
5 |
cerebellum |
5 |
cerebral ischemia |
5 |
cervical cancer |
5 |
chicken |
5 |
chicken meat |
5 |
child, hospitalized |
5 |
childhood lymphoma |
5 |
children. |
5 |
chlorides - diagnostic use |
5 |
chondrocytes - metabolism |
5 |
chondroitin sulfate |
5 |
chromosomes, human, pair 9 - genetics |
5 |
chronic inflammatory demyelinating polyneuropathy |
5 |
clec5a |
5 |
clinical article |
5 |
clinical genetics and dysmorphology |
5 |
clinical trials |
5 |
cmv |
5 |
cofactors |
5 |
collagen - immunology |
5 |
communication |
5 |
complement |
5 |
congenital hypothyroidism |
5 |
congenital malformations |
5 |
consensus |
5 |
cord blood stem cell |
5 |
counseling |
5 |
covid-19 vaccines |
5 |
craniopharyngioma |
5 |
crohn disease |
5 |
cystic fibrosis |
5 |
cytomegalovirus - drug effects - genetics - isolation & purification |
5 |
cytoskeletal proteins - genetics |
5 |
demography |
5 |
dendritic cells - immunology - microbiology - virology |
5 |
deoxyribonucleases, type ii site-specific |
5 |
depressive symptoms |
5 |
dilated cardiomyopathy |
5 |
diphosphonates - pharmacology |
5 |
direction infection |
5 |
disease outbreaks |
5 |
disease transmission, vertical - prevention & control |
5 |
dna, neoplasm - genetics |
5 |
dna, viral - blood - drug effects |
5 |
dyskeratosis congenita |
5 |
early motherhood |
5 |
early stimulation |
5 |
ebv‐encoded small rna |
5 |
eczema |
5 |
elderly |
5 |
electric stimulation |
5 |
empowerment |
5 |
empyema |
5 |
encephalities |
5 |
epidemiologic methods |
5 |
epilepsy - genetics |
5 |
esophageal leiomyoma |
5 |
extended-spectrum beta-lactamases |
5 |
family cohesion |
5 |
family support |
5 |
feces analysis |
5 |
fetal blood - chemistry |
5 |
fetal hemoglobin |
5 |
fetal hemoglobin - biosynthesis |
5 |
fetal tissue transplantation |
5 |
fever - etiology - therapy |
5 |
flow cytometry |
5 |
frameshift mutation |
5 |
gamma ifn |
5 |